Trial watch: chemotherapy-induced immunogenic cell death in oncology

Trial watch: chemotherapy-induced immunogenic cell death in oncology

ABSTRACTImmunogenic cell death (ICD) refers to an immunologically distinct process of regulated cell death that activates, rather than suppresses, innate and adaptive immune responses. Such responses culminate into T cell-driven immunity against antigens derived from dying cancer cells. The potency...

Full description

Bibliographic Details
Main Authors: Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, Jannes Govaerts, Stefan Naulaerts, Daniel M. Borras, Lisa Kinget, Jitka Fucíková, Radek Špíšek, Lenka Palová Jelínková, Oliver Kepp, Guido Kroemer, Dmitri V. Krysko, An Coosemans, Rianne D.W. Vaes, Dirk De Ruysscher, Steven De Vleeschouwer, Els Wauters, Evelien Smits, Sabine Tejpar, Benoit Beuselinck, Sigrid Hatse, Hans Wildiers, Paul M. Clement, Peter Vandenabeele, Laurence Zitvogel, Abhishek D. Garg
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:OncoImmunology
Subjects:
CAR T cells, antigen-presenting cells
chemotherapy
danger signals
dendritic cell
immune-checkpoint blockers
immunogenic cell death
Online Access:https://www.tandfonline.com/doi/10.1080/2162402X.2023.2219591

Internet

https://www.tandfonline.com/doi/10.1080/2162402X.2023.2219591

Similar Items